Skip to main content
VCbacked
Log inGet Started

ZetaGen Therapeutics

Syracuse, United States

ZetaGen Therapeutics commercializes a small molecule-based osteoinductive platform.

$12.9M raised
Jan 2025
Series B
Health CareMedical DeviceTherapeutics

Top Investors

National Cancer InstituteNew York VenturesJStar Capital InvestmentsMedTech InnovatorConsolidated Investment Group

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about ZetaGen Therapeutics

How much funding has ZetaGen Therapeutics raised?
ZetaGen Therapeutics has raised $12.9M in total funding. The most recent round was Series B. The last funding was announced in January 2025.
Who are ZetaGen Therapeutics's investors?
ZetaGen Therapeutics's investors include National Cancer Institute, New York Ventures, JStar Capital Investments, MedTech Innovator, Consolidated Investment Group.
Where is ZetaGen Therapeutics headquartered?
ZetaGen Therapeutics is headquartered in Syracuse, United States.
What does ZetaGen Therapeutics do?
ZetaGen Therapeutics commercializes a small molecule-based osteoinductive platform.
What stage is ZetaGen Therapeutics at?
ZetaGen Therapeutics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"ZetaGen Therapeutics — Funding & Investors." VCBacked, January 23, 2025, https://www.vcbacked.co/company/zetagen-therapeutics. Accessed July 1, 2026.
APA
VCBacked. (2025). ZetaGen Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/zetagen-therapeutics
Wikipedia (cite web)
{{cite web |title=ZetaGen Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/zetagen-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Health Care

View all
Oryl Photonics
Lausanne
Allterum Therapeutics
Houston$1.0M
Rapport Therapeutics
Boston$250.0M
OncoRevive
Brunswick$119K
Circl Brain Health Metrics
Victoria$354K
YLAH
Bern$589K